Stem cells and heart disease - Brake or accelerator?

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Despite two decades of research, stem cell therapies for cardiac diseases have not achieved clinical success.
• Current clinical outcomes do not align with experimental evidence, indicating significant obstacles.
• A disconnect exists between knowledge of tissue repair and underlying disease mechanisms.

Purpose of the Study:

• To identify obstacles hindering stem cell therapy for cardiac diseases.
• To focus on underlying disease mechanisms as targets for regenerative therapies.
• To propose a redirection of stem cell therapy practices based on new insights.

Main Methods:

• Review of existing literature and clinical trial data.
• Analysis of stem cell dysfunction and gene defects in cardiovascular repair.
• Focus on integrating knowledge from tissue repair and disease pathology.

Main Results:

• Stem cell dysfunction and genetic defects in repair mechanisms contribute to atherosclerosis and heart disease.
• Clinical translation is hampered by a lack of integrated understanding of repair and disease.
• Current stem cell therapy approaches may not adequately address disease mechanisms.

Conclusions:

• Stem cell therapy for cardiac diseases requires a paradigm shift, focusing on disease mechanisms.
• More detailed analysis of stem cell function in relation to disease is crucial.
• Intensified unified computational data analysis and open-access data sharing are recommended to accelerate progress.